Showing results (1031-1040 of 3,660) with videos related to
Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|February 4, 2026
Predicting progression-free survival in hormone-receptor positive (HR+/HER2-) metastatic breast cancer (MBC) treated with CDK4/6 inhibitors: A machine learning approachSergio Pannunzio, Luca Mastrantoni, Noemi Maliziola, et al.Breast (Edinburgh, Scotland)|January 17, 2026
Breast composition and dose deposition to fat and fibroglandular tissues are associated with breast side effects after radiation therapyTanwiwat Jaikuna, Fiona Wilson, Carmel Anandadas, et al.Breast (Edinburgh, Scotland)|March 22, 2025
Comparison of oncological outcomes of premenopausal with ovarian function suppression versus postmenopausal women in ER+/HER2- breast cancerMin Jung Lee, Ji-Jung Jung, Jong-Ho Cheun, et al.Breast (Edinburgh, Scotland)|March 16, 2025
Trajectories and predictors of financial toxicity in breast cancer patients: A multicenter longitudinal study in ChinaYi Kuang, Jiajia Qiu, Ye Liu, et al.Breast (Edinburgh, Scotland)|December 9, 2003
New data on chemotherapy in the adjuvant settingM J Piccart, C Sotiriou, F CardosoBreast (Edinburgh, Scotland)|December 9, 2003
Efforts to link biological and clinical breast cancer researchMitch DowsettBreast (Edinburgh, Scotland)|December 9, 2003
The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor RegistryElizabeth B Claus, Meredith Stowe, Darryl Carter, et al.Breast (Edinburgh, Scotland)|December 9, 2003
Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin statusMelvin J Silverstein, Claire BuchananBreast (Edinburgh, Scotland)|December 9, 2003
Adjuvant therapy for older women with breast cancerH B MussBreast (Edinburgh, Scotland)|December 9, 2003
The anti-tumor potential of zoledronic acidP Croucher, S Jagdev, R ColemanPageof 366